• DHHC9-STRN4 Palmitoylation Axis Drives YAP-Mediated Metastas

  2026-05-11

  This article reviews recent evidence linking DHHC9-mediated palmitoylation of STRN4 to enhanced YAP-driven cancer metastasis, as reported in a 2025 Journal of Cellular and Molecular Medicine study. The findings highlight a novel regulatory mechanism and identify small-molecule DHHC9 inhibitors as promising anti-metastatic agents.

• Bacillus Strain and Medium Choice Drive γ-Glu-Cys Peptide Yi

  2026-05-11

  This study systematically evaluates how Bacillus species and culture media influence the generation of γ-glutamyl peptides, with a focus on the key intermediate gamma-Glu-Cys (γ-Glu-Cys). The findings reveal that hemoglobin hydrolysate medium substantially boosts peptide production, informing optimized protocols for glutathione metabolism research and kokumi peptide engineering.

• Protein A/G Magnetic Beads: Practical Guidance for IP & Ch-I

  2026-05-10

  Protein A/G Magnetic Beads (SKU K1305) enable efficient purification of IgG antibodies and facilitate immunoprecipitation-based analysis in complex biological samples, reducing background due to minimized non-specific binding. These beads are best used for antibody capture and protein-protein interaction studies, not for diagnostic or clinical applications. Their design supports reproducible, low-interference workflows in research environments.

• Ciclesonide: Mechanistic Precision and Strategic Leverage in

  2026-05-09

  This thought-leadership article explores the mechanistic underpinnings and translational opportunities of Ciclesonide, focusing on its unique prodrug activation, potent glucocorticoid receptor binding, and anti-inflammatory efficacy in respiratory models. By contextualizing Ciclesonide within the evolving landscape of targeted protein degradation, including recent ERAD-hijacking technologies, the article provides actionable guidance for researchers aiming to enhance reproducibility and translational impact in asthma and allergic rhinitis studies.

• (+)-Bicuculline: Protocol Guidance for GABAA Antagonism

  2026-05-08

  (+)-Bicuculline serves as a classical GABAA receptor antagonist, enabling precise dissection of inhibitory synaptic transmission and GABAergic signaling in neuroscience research. It is not suited for clinical, diagnostic, or therapeutic purposes, and correct handling is critical for experimental reliability.

• Strategic Application of FDA-Approved Drug Libraries in Tran

  2026-05-08

  Explore a thought-leadership perspective on leveraging the DiscoveryProbe™ FDA-approved Drug Library for high-throughput screening, drug repositioning, and pharmacological target identification. This article synthesizes mechanistic insights from recent viral protease inhibitor research, outlines practical assay considerations, and provides a strategic roadmap for translational scientists seeking accelerated pathways from bench to bedside.

• Doxorubicin Hydrochloride: Innovations in Cardiotoxicity Mod

  2026-05-07

  Explore how Doxorubicin hydrochloride (Adriamycin HCl) is revolutionizing cardiotoxicity and cancer chemotherapy research. This in-depth analysis reveals the latest mechanistic insights and translational applications for advanced assay design.

• Genome and Transcriptome Instability Drives CRC Metastasis H

  2026-05-07

  Cho et al. present a comprehensive analysis of genomic and transcriptomic instability during colorectal cancer (CRC) metastasis, using patient-derived xenograft (PDX) models. Their findings link subclonal evolution with therapeutic heterogeneity, highlighting the challenges of drug resistance and the need for adaptive research models.

• BML-277: Precision Chk2 Inhibition for Genome Stability Insi

  2026-05-06

  Explore how BML-277, a potent Chk2 inhibitor, enables precise dissection of DNA damage response pathways and radioprotection of T-cells. This article uniquely integrates mechanistic evidence and protocol parameters to guide advanced genome stability research.

• ABT-263 (Navitoclax): Applied Strategies for Apoptosis Assay

  2026-05-06

  ABT-263 (Navitoclax) is redefining apoptosis research by providing robust, quantifiable inhibition of Bcl-2 family proteins—enabling reproducible caspase-dependent apoptosis assays and precise modeling of cancer cell death. This article details workflow enhancements, reference-driven use-cases, and practical troubleshooting tips to maximize data quality in oncology and senescence studies.

• E. coli Uracil-DNA Glycosylase (UDG): Practical Workflow Gui

  2026-05-05

  E. coli Uracil-DNA Glycosylase (UDG) provides precise removal of uracil residues from DNA, minimizing PCR product contamination and supporting DNA repair enzyme studies. It is optimized for research applications involving DNA templates, but should not be used for RNA or very short oligonucleotide substrates.

• Balancing Self-Renewal and Differentiation in Human Intestin

  2026-05-05

  This article reviews a recent study that introduces a tunable human intestinal organoid system achieving controlled balance between stem cell self-renewal and differentiation. The findings have significant implications for scalable organoid culture and high-throughput research in tissue modeling and disease studies.

• Thiazovivin (A5506): Practical Guide for ROCK Inhibition

  2026-05-04

  Thiazovivin is a high-purity ROCK inhibitor designed to enhance fibroblast reprogramming and human embryonic stem cell survival. It is best suited for workflows requiring efficient induced pluripotent stem cell generation and robust post-trypsinization recovery. Its use is not recommended for diagnostic or clinical applications.

• Penicillin G Sodium: Scientific Advances in Bacterial Cell W

  2026-05-04

  Explore the profound science of Penicillin G Sodium, a leading natural penicillin antibiotic. This article delves into its molecular mechanism, comparative efficacy, and the latest research on bacterial cell wall biosynthesis inhibition—offering insights beyond contamination control.

• Clozapine N-oxide: Precision Chemogenetic Control in Neurosc

  2026-05-03

  Clozapine N-oxide (CNO) empowers researchers to non-invasively modulate neuronal circuits with unmatched selectivity, making it indispensable for DREADDs-based studies and GPCR signaling research. This article demystifies experimental workflows, uncovers troubleshooting strategies, and leverages insights from recent literature to maximize the reliability of CNO-driven assays.

11343 records 1/757 page Next 12345 下5页 Last page